Seaport Therapeutics SPTX
NASDAQ SPTX
$19.12 -0.86 (-4.30%)
At close: Nov 16, 2026 · 4:00 PM EST

Seaport Therapeutics (SPTX) Sale and Maturity of Investments (2025 - 2026)

Updated

Seaport Therapeutics (SPTX) posted Sale and Maturity of Investments - Total of $45 million for Q3 2026, down 30.8% from $65 million a year earlier and down 10.0% from the prior quarter.

Analysis

Seaport Therapeutics (SPTX) Sale and Maturity of Investments (2025 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Sale and Maturity of Investments - Total at Seaport Therapeutics was $240 million; for FY2025, it came in at $212.5 million.

  • According to Business Quant data, Sale and Maturity of Investments - Total for the three prior quarters was $50 million (Q2 2026), $75 million (Q1 2026) and $70 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 308.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 405.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - 88.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.53 Bn
10 Seaport Therapeutics 1.03 Bn 63.31 Mn - 45.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 45.00 Mn
Jun 30, 2026 50.00 Mn
Mar 31, 2026 75.00 Mn
Dec 31, 2025 70.00 Mn
Sep 30, 2025 65.00 Mn
Jun 30, 2025 77.50 Mn
API Access

Seaport Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=SPTX&period=max&api_key=YOUR_API_KEY